COMPASS PATHWAYS PLC (CMPS) Stock News

USA - NASDAQ:CMPS - US20451W1018 - ADR

5.86 USD

+0.16 (+2.81%)

Last: 11/12/2025, 8:07:56 PM

5.8506 USD

-0.01 (-0.16%)

After Hours: 11/12/2025, 8:07:56 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CMPS Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Compass Pathfinder Limited

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

9 days ago - By: Benzinga - Mentions: SRPT EVOK QURE RLMD ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

9 days ago - By: Compass Pathfinder Limited

Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months

9 days ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

3 months ago - By: The Motley Fool

Compass (CMPS) Q2 Loss Improves 27%

14 days ago - By: NeuroKaire

NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression

15 days ago - By: Compass Pathfinder Limited

Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

16 days ago - By: Compass Pathfinder Limited

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

2 months ago - By: Design Therapeutics, Inc. - Mentions: DSGN XENE

Design Therapeutics Appoints Justin Gover to Board of Directors

2 months ago - By: Compass Pathfinder Limited

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

3 months ago - By: Compass Pathfinder Limited

Compass Pathways to Participate in Four Investor Conferences in September

3 months ago - By: Yahoo Finance - Mentions: RY RY.CA ABBV

AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug

3 months ago - By: Compass Pathfinder Limited

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

3 months ago - By: Compass Pathfinder

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

4 months ago - By: Compass Pathfinder Limited

Compass Pathways Appoints Justin Gover to Board of Directors

4 months ago - By: Compass Pathfinder Limited

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

4 months ago - By: The Motley Fool - Mentions: VKTX

These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?

4 months ago - By: Yahoo Finance

Cathie Wood’s ARK Adds 125K COMPASS Pathways plc (CMPS) Shares

4 months ago - By: Compass Pathfinder Limited

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

4 months ago - By: FN Media Group LLC - Mentions: NYSE SAGE MNMD ATAI

Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

5 months ago - By: Yahoo Finance - Mentions: BABA

This Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip?

5 months ago - By: Stocktwits

Stifel Says Compass Pathways Selloff 'Significantly Overdone' After Psilocybin Trial Data

5 months ago - By: Stocktwits - Mentions: PSIL SBIO

Compass Pathways Stock Slumps After Positive Late-Stage Trial Results From Psychedelic Drug ‘Underwhelm’ Analysts

5 months ago - By: Bloomberg

Compass’s Psychedelic Drug to Treat Depression Meets Goal in Trial

5 months ago - By: Compass Pathfinder Limited

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression